Grants for Small businesses - Science and Technology

The Chesapeake Oyster Innovation Award Program, offered by the Chesapeake Bay Trust and supported by the Chesapeake Bay Foundation, aims to increase knowledge of the value of oysters, advance technologies for increasing oyster populations or aquaculture production, and improve oyster population monitoring techniques. This program supports projects in Maryland and Virginia and welcomes requests from members of the Chesapeake Oyster Alliance, including community organizations and both for-profit and nonprofit organizations. The grant awards up to $10,000, with applications due by September 19, 2024. Match is encouraged but not required.

This grant provides substantial funding to early-career researchers dedicated to innovative breast cancer research, emphasizing collaboration and the involvement of breast cancer advocates.

This funding opportunity supports research into innovative energy generation and storage technologies for military and commercial applications, focusing on their reliability and integration into electrified systems.

This funding opportunity supports U.S. institutions conducting clinical trials on innovative regenerative medicine therapies using adult stem cells, focusing on extending research from previously funded projects.

Supports the construction, purchase, expansion, or upgrade of workforce or training-related infrastructure to better meet the needs of the offshore wind industry.

This grant provides funding for research institutions and companies to develop innovative tactics and technologies for small groups of autonomous systems to effectively maneuver in complex military environments.

This funding opportunity supports innovative research and interventions aimed at combating the opioid epidemic in Kentucky, targeting organizations that address opioid use disorder and related mental health issues.

This funding opportunity supports Arizona-based institutions conducting clinical research on ibogaine to treat neurological diseases, aiming to advance health and wellness for residents through innovative, collaborative projects.

This funding opportunity supports projects that develop and operate geologic field laboratories for carbon storage technology, targeting organizations with access to suitable sites for testing and advancing carbon capture solutions.

This funding opportunity provides financial support to U.S.-based small businesses for innovative research and development projects that address critical challenges in energy, environment, and national security.

This grant supports entrepreneurs and researchers in Pennsylvania by providing resources and funding to help turn innovative ideas into marketable products and services that benefit the community and beyond.

This funding opportunity provides financial support for innovative projects that aim to improve the development of treatments for ultra-rare cancers, targeting both pediatric and adult populations, and is open to a variety of U.S.-based organizations and institutions.

This grant provides researchers access to valuable biospecimens and data from a national health initiative to conduct large-scale studies that advance precision medicine and improve understanding of health outcomes.

The FY24 OCRP Clinical Trial Translational Endpoints Research Award intends to support correlation of clinical trial-related data (e.g., biosample analysis, imaging, or epidemiological data) with clinical outcomes or responses to therapies. Correlative studies may be associated with a past, ongoing, or future clinical trial in order to associate various factors (genetic, DOD FY24 Ovarian Cancer Clinical Trial Translational Endpoints Research Award 4biochemical, environmental and others) with initiation, progression, metastasis, recurrence, prognosis, diagnosis or effect of intervention on ovarian cancer outcomes. The translational research should address high-impact or unmet needs in ovarian cancer. The proposed research may be hypothesis testing or may be designed to generate new hypotheses to be tested in follow-up clinical research. The award may not be used to directly support a clinical trial.

The Nebraska SBIR/STTR Initiative provides financial assistance to small businesses in Nebraska participating in the federal SBIR/STTR programs. This state initiative offers Phase 0 assistance to help businesses apply for federal Phase 1 funding and matching funds for successful Phase 1 and Phase 2 federal awards. The initiative aims to promote innovation and technology transfer among small businesses in Nebraska, with a total fund availability of up to $6 million per year. Grant renewed every year. Grant Annual opening/closing deadline: July 1st to June 30th

This program provides financial assistance to businesses in Wabasha for improving the exterior of their commercial or industrial buildings, promoting revitalization and private investment in the community.

The DoD Kidney Cancer, Clinical Trial Award is a funding opportunity aimed at supporting the implementation of clinical trials that have the potential to significantly impact the treatment or management of kidney cancer, with a focus on new products, pharmacologic agents, devices, clinical guidance, and emerging approaches and technologies.

The Heartland Regional Food Business Center is offering Business Builder Subawards ranging from $5,000 to $50,000 to support small food and farm businesses in selected states and counties, aiming to expand local and regional food markets, increase business acumen, and strengthen food systems in response to COVID-19, with projects to be completed within a year.

This ISO seeks solution summary and proposal submissions for projects that fall within the scope of the ARPA-H mission Resilient Systems Office (RSO). RSOs interest areas will address systemic challenges across the healthcare and public health landscape by investing in cutting-edge technologies that address long-standing gaps in the quality, efficacy, and consistent availability of care.Aspects of todays health and public health systems remain fragile due to systemic challenges, which include rising healthcare costs, inadequate healthcare coverage for significant populations, outdated infrastructure, and health disparities among different demographic groups. Acute challenges, such as hospital closures, supply chain disruptions, staffing shortages, cyber-attacks, public health crises, and the emergence of new diseases, further exacerbate existing fragilities, making it more difficult to maintain high standards of care. These challenges are compounded by the fact that systems remain fragmented, hindering the ability to gain comprehensive insights, make informed decisions, develop tailored interventions, and share critical health information between stakeholders.RSO seeks solution summaries and proposals that drive innovations to enhance the adaptability, reliability, and interoperability of the health ecosystem. Of interest are innovations that foster flexibility and enable adaptation to system stressors, so that people and systems remain well-positioned to deliver high-quality care and improve health outcomes. The following interest areas categorize the ground-breaking research we seek to support:Sociotechnical System Innovation: Innovate user-centric digital health tools, platforms, technologies, and intervention models that improve outcomes across the health continuum, including prevention, diagnosis, and treatment of physical, mental, and behavioral health. Approaches to build trust in the healthcare system and distribute high-quality health guidance in an understandable manner that improves patient outcomes. Novel real-time measurement tools to track health outcomes, evaluate post-market performance of new interventions, and enable convergence on the most effective strategies to improve the quality of care, especially for underserved communities. Other population centered innovations to create more resilient communities and subpopulations. Innovations might include aggregate improvements to quality of care and better physical, mental, and behavioral health outcomes for the health ecosystem.Health Ecosystem Integration: Novel ways to collect, protect, secure, integrate, analyze, communicate, and present health data, including but not limited to advances in privacy, cyber security, artificial intelligence with enhanced patient safety properties, low-code or no-code technologies, semantic approaches, and rapid integration techniques. Strategies and technologies to leverage homes, community centers, pharmacies, and other accessible locations to enable new modalities of high-quality care, expand the reach of clinical research, or integrate end-user feedback to rapidly iterate prototype designs. Approaches to strengthen the connectivity and interoperability of health data and devices to 5 enable the safe, secure, and seamless exchange of information among healthcare providers, researchers, and stakeholders. Other novel approaches to increase the interoperability of health-related systems in support of improved health outcomes and enhanced transparency across the health ecosystem.Adaptive Antifragile Solutions: Creative approaches to enhance the stability and dependability of the health ecosystem through new adaptive paradigms, methods that anticipate and mitigate disruptions before they occur, and enhancements to emergency response. Approaches that enable health infrastructure to rapidly integrate information from new sensors; create decision support tools; adapt supply chains, manufacturing, and logistics; and better leverage the workforce during public health emergencies. Novel methods to engineer resilient tissues, microbiomes, and biophysical systems to combat disease or maintain health. Other novel approaches to enhance adaptability and reduce fragility within the health ecosystem.Proposals are expected to use innovative approaches to enable revolutionary advances in science, technology, systems, or methodology. Specifically excluded are proposals that represent an evolutionary or incremental advance in the state of the art or technology that has reached the clinical trial stage. Additionally, proposals directed towards policy changes, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission

This funding opportunity provides financial support for innovative breast cancer research projects aimed at preventing the disease, understanding its recurrence, or improving treatment, targeting both early-stage and more developed studies from a range of eligible organizations and researchers.